Previous Article | Next Article ![]()
Infection and Immunity, March 2000, p. 1040-1047, Vol. 68, No. 3
Department of
Virology1 and Laboratory of
Mycobacterial Immunology,2 Pasteur Institute
of Brussels, 1180 Brussels, Belgium
Received 6 July 1999/Returned for modification 26 August
1999/Accepted 1 December 1999
Using spleen cells from mice vaccinated with live
Mycobacterium bovis BCG, we previously generated three
monoclonal antibodies reactive against a 22-kDa protein present in
mycobacterial culture filtrate (CF) (K. Huygen et al., Infect. Immun.
61:2687-2693, 1993). These monoclonal antibodies were used
to screen an M. bovis BCG genomic library made in phage
0019-9567/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
Cloning of the Gene Encoding a
22-Kilodalton Cell Surface Antigen of Mycobacterium bovis
BCG and Analysis of Its Potential for DNA Vaccination against
Tuberculosis

gt11. The gene encoding a 233-amino-acid (aa) protein, including a
putative 26-aa signal sequence, was isolated, and sequence analysis
indicated that the protein was 98% identical with the M. tuberculosis Lppx protein and that it contained a sequence 94%
identical with the M. leprae 38-mer polypeptide 13B3
recognized by T cells from killed M. leprae-immunized
subjects. Flow cytometry and cell fractionation demonstrated that the
22-kDa CF protein is also highly expressed in the bacterial cell wall and membrane compartment but not in the cytosol. C57BL/6, C3H, and
BALB/c mice were vaccinated with plasmid DNA encoding the 22-kDa
protein and analyzed for immune response and protection against
intravenous M. tuberculosis challenge. Whereas DNA
vaccination induced elevated antibody responses in C57BL/6 and
particularly in C3H mice, Th1-type cytokine response, as measured by
interleukin-2 and gamma interferon secretion, was only modest, and no
protection against intravenous M. tuberculosis challenge
was observed in any of the three mouse strains tested. Therefore, the
22-kDa antigen seems to have little potential for a DNA vaccine against
tuberculosis, but it may be a good candidate for a mycobacterial
antigen detection test.
*
Corresponding author. Mailing address: Pasteur
Institute of Brussels, Laboratory of Mycobacterial Immunology, 642 Engelandstraat, 1180 Brussels, Belgium. Phone: 32.2.373.33.70. Fax:
32.2.373.33.67. E-mail: chuygen{at}ben.vub.ac.be.
Deceased.
This article has been cited by other articles:
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»